BindingDB logo
myBDB logout

BDBM191101 US9181258, 97

SMILES: NCC[C@H]1CNC(=O)c2cc(c(-c3ccc(C=O)cc3)n12)-c1cccc(OC(F)(F)F)c1

InChI Key: InChIKey=DGAUZJLZJIGTFD-KRWDZBQOSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 191101   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Serine/threonine-protein kinase pim-2


(Homo sapiens (Human))
BDBM191101
PNG
(US9181258, 97)
Show SMILES NCC[C@H]1CNC(=O)c2cc(c(-c3ccc(C=O)cc3)n12)-c1cccc(OC(F)(F)F)c1
Show InChI InChI=1S/C23H20F3N3O3/c24-23(25,26)32-18-3-1-2-16(10-18)19-11-20-22(31)28-12-17(8-9-27)29(20)21(19)15-6-4-14(13-30)5-7-15/h1-7,10-11,13,17H,8-9,12,27H2,(H,28,31)/t17-/m0/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 22n/an/an/an/a7.5n/a



NERVIANO MEDICAL SCIENCES S.R.L.

US Patent


Assay Description
The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Speci...


US Patent US9181258 (2015)


BindingDB Entry DOI: 10.7270/Q2862F7F
More data for this
Ligand-Target Pair
Serine/threonine-protein kinase pim-1


(Homo sapiens (Human))
BDBM191101
PNG
(US9181258, 97)
Show SMILES NCC[C@H]1CNC(=O)c2cc(c(-c3ccc(C=O)cc3)n12)-c1cccc(OC(F)(F)F)c1
Show InChI InChI=1S/C23H20F3N3O3/c24-23(25,26)32-18-3-1-2-16(10-18)19-11-20-22(31)28-12-17(8-9-27)29(20)21(19)15-6-4-14(13-30)5-7-15/h1-7,10-11,13,17H,8-9,12,27H2,(H,28,31)/t17-/m0/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 7n/an/an/an/a7.5n/a



NERVIANO MEDICAL SCIENCES S.R.L.

US Patent


Assay Description
The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay. Spec...


US Patent US9181258 (2015)


BindingDB Entry DOI: 10.7270/Q2862F7F
More data for this
Ligand-Target Pair